Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 3
Submit an article Journal homepage
632
Views
45
CrossRef citations to date
0
Altmetric
Letter

High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study

Luana FianchiIstituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy
,
Marianna CriscuoloIstituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy
,
Massimo BrecciaDipartimento di Biotecnologie Cellulari ed Ematologia, Università La Sapienza, Roma, Italy
,
Luca MaurilloIstituto di Ematologia, Fondazione Policlinico Tor Vergata, Roma, Italy
,
Flavia SalviEmatologia, A.O. SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
,
Pellegrino MustoDipartimento di Onco-Hematology, IRCCS, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture, Italy
,
Giovanna MansuetoDipartimento di Onco-Hematology, IRCCS, Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture, Italy
,
Gianluca GaidanoDivisione di Ematologia, Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale Amedeo Avogadro, Novara, Italy
,
Carlo FinelliS.Orsola-Malpighi University Hospital, Department of Hematology and Oncological Sciences “Seràgnoli”, Bologna, Italy
,
Antonietta Aloe-SpiritiDipartimento di Ematologia, Ospedale Sant’Andrea, Università La Sapienza, Roma, Italy
,
Valeria SantiniEmatologia, AOU Careggi, Università di Firenze, Firenze, Italy
,
Mariangelo GrecoDivisione di Ematologia, Dipartimento di Medicina Traslazionale, Università del Piemonte Orientale Amedeo Avogadro, Novara, Italy
,
Stefan HohausIstituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy
,
Giuseppe LeoneIstituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, Italy
&
Maria Teresa VosoIstituto di Ematologia, Università Cattolica del Sacro Cuore, Roma, ItalyCorrespondence[email protected]
 show all
Pages 658-661 | Received 29 Jun 2012, Accepted 29 Jul 2012, Published online: 30 Aug 2012

Citations (45)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Arnaud Lesegretain, Andrew Brunner, Aziz Benzohra & Amir T. Fathi. (2023) Temporal trend in survival for chronic myelomonocytic leukemia in the US: a population-based study. Leukemia & Lymphoma 0:0, pages 1-9.
Read now
Thomas P. Thomopoulos, Anthi Bouhla, Sotirios G. Papageorgiou & Vasiliki Pappa. (2021) Chronic myelomonocytic leukemia - a review. Expert Review of Hematology 14:1, pages 59-77.
Read now
Ruohao Xu, Minming Li, Ping Wu, Chengxin Deng, Suxia Geng, Xin Huang, Jianyu Weng & Xin Du. (2021) Hypomethylating agents in the treatment of chronic myelomonocytic leukemia: a meta-analysis and systematic review. Hematology 26:1, pages 312-320.
Read now
Jorge Ramos Perez & Guillermo Montalban-Bravo. (2020) Emerging drugs for the treatment of chronic myelomonocytic leukemia. Expert Opinion on Emerging Drugs 25:4, pages 515-529.
Read now
Panagiotis T. Diamantopoulos, Ioannis Kotsianidis, Argiris Symeonidis, Vassiliki Pappa, Athanasios Galanopoulos, Dimitrios Gogos, Stamatios Karakatsanis, Helen Papadaki, Aikaterini Palla, Eleftheria Hatzimichael, Maria Dimou, Sotirios Papageorgiou, Sosana Delimpasis, Maria Papaioannou, Menelaos Papoutselis, Alexandra Kourakli, Dimitrios Tsokanas, Achilles Anagnostopoulos, Christos K. Kontos, Panayiotis Panayiotidis & Nora-Athina Viniou. (2019) Chronic myelomonocytic leukemia treated with 5-azacytidine – results from the Hellenic 5-Azacytidine Registry: proposal of a new risk stratification system. Leukemia & Lymphoma 60:7, pages 1721-1730.
Read now
Sonja Burgstaller, Reinhard Stauder, Thomas Kuehr, Alois Lang, Sigrid Machherndl-Spandl, Beate Mayrbaeurl, Thomas Noesslinger, Andreas Petzer, Peter Valent, Richard Greil & Josef Thaler. (2018) A phase I study of lenalidomide in patients with chronic myelomonocytic leukemia (CMML) – AGMT_CMML-1. Leukemia & Lymphoma 59:5, pages 1121-1126.
Read now

Articles from other publishers (39)

Margo B. Gerke, Ilias Christodoulou & Theodoros Karantanos. (2023) Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms. Cancers 15:15, pages 3815.
Crossref
Takeshi Hagino, Tomohiko Sato, Reina Saga, Hiroko Hidai, Yoshiro Murai, Hideki Akiyama & Sayuri Motomura. (2022) Myeloid leukemoid reaction after initial azacitidine therapy for chronic myelomonocytic leukemia. International Journal of Hematology 116:6, pages 961-965.
Crossref
Xinhui Zheng, Liwei Lv, Xiangjun Li & Erlie Jiang. (2022) Efficacy and Safety of Hypomethylating Agents in Chronic Myelomonocytic Leukemia: A Single-Arm Meta-analysis. Global Medical Genetics 09:02, pages 141-151.
Crossref
A. Triguero, B. Xicoy, L. Zamora, MJ. Jiménez, O. García, M. Calabuig, M. Díaz-Beyá, J. Arzuaga, F. Ramos, A. Medina, T. Bernal, C. Talarn, R. Coll, R. Collado, T.Hua Chen, J. Borrás, S. Brunet, I. Marchante, V. Marco, F. López-Cadenas, M. Calbacho, A. Simiele, M. Cortés, MT. Cedena, M. Pedreño, C. Aguilar, C. Pedró, M. Fernández, C. Stoica, JM. Ribera & G. Sanz. (2022) Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria. Leukemia Research 116, pages 106836.
Crossref
Mrinal M. Patnaik & Ayalew Tefferi. (2022) Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management. American Journal of Hematology 97:3, pages 352-372.
Crossref
Konstantinos Liapis & Ioannis Kotsianidis. (2021) Approaching First-Line Treatment in Patients With Advanced CMML: Hypomethylating Agents or Cytotoxic Treatment?. Frontiers in Oncology 11.
Crossref
Onyee Chan, Aline Renneville & Eric Padron. (2021) Chronic myelomonocytic leukemia diagnosis and management. Leukemia 35:6, pages 1552-1562.
Crossref
Douglas Tremblay, Noa Rippel, Jonathan Feld, Siraj M. El Jamal & John Mascarenhas. (2021) Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia. The Oncologist 26:5, pages 406-421.
Crossref
Jihyun Kwon. (2021) Diagnosis and treatment of chronic myelomonocytic leukemia. BLOOD RESEARCH 56:S1, pages S5-S16.
Crossref
Johannes Nowatzky & İzzet Fresko. 2020. Behçet Syndrome. Behçet Syndrome 143 160 .
Mrinal M. Patnaik & Ayalew Tefferi. (2019) Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management. American Journal of Hematology 95:1, pages 97-115.
Crossref
Hany Elmariah & Amy E. DeZern. (2019) Chronic Myelomonocytic Leukemia: 2018 Update to Prognosis and Treatment. Current Hematologic Malignancy Reports 14:3, pages 154-163.
Crossref
Roman M. Shapiro & Alejandro Lazo-Langner. (2018) Systematic review of azacitidine regimens in myelodysplastic syndrome and acute myeloid leukemia. BMC Hematology 18:1.
Crossref
Raphael Itzykson, Pierre Fenaux, David Bowen, Nicholas C.P. Cross, Jorge Cortes, Theo De Witte, Ulrich Germing, Francesco Onida, Eric Padron, Uwe Platzbecker, Valeria Santini, Guillermo F. Sanz, Eric Solary, Arjan Van de Loosdrecht & Luca Malcovati. (2018) Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults. HemaSphere 2:6, pages e150.
Crossref
Anthony M. Hunter, Ling Zhang & Eric Padron. (2018) Current Management and Recent Advances in the Treatment of Chronic Myelomonocytic Leukemia. Current Treatment Options in Oncology 19:12.
Crossref
Elvira Mora & Guillermo F. Sanz. (2018) Current management of patients with chronic myelomonocytic leukemia. Current Opinion in Oncology 30:6, pages 409-417.
Crossref
Mrinal M. Patnaik & Ayalew Tefferi. (2018) Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management. American Journal of Hematology 93:6, pages 824-840.
Crossref
Matthieu Duchmann, Nolwenn Lucas, Raphael Itzykson & Eric Solary. 2018. Myelodysplastic Syndromes. Myelodysplastic Syndromes 65 79 .
Michael Gentry & Eric D. Hsi. 2018. Precision Molecular Pathology of Myeloid Neoplasms. Precision Molecular Pathology of Myeloid Neoplasms 233 247 .
Tamara K. Moyo & Michael R. Savona. (2017) Therapy for Chronic Myelomonocytic Leukemia in a New Era. Current Hematologic Malignancy Reports 12:5, pages 468-477.
Crossref
Pasquale Niscola, Andrea Tendas, Elisabetta Abruzzese, Tommaso Caravita, Luca Cupelli, Marco Giovannini, Laura Scaramucci, Agostina Siniscalchi, Monika Malgorzata Trawinska & Paolo de Fabritiis. (2017) Advanced chronic myelomonocytic leukemia in elderly and frail patients managed by azacitidine in the field of clinical practice. Annals of Hematology 96:9, pages 1591-1593.
Crossref
Ana Alfonso, Guillermo Montalban-Bravo, Koichi Takahashi, Elias J. Jabbour, Tapan Kadia, Farhad Ravandi, Jorge Cortes, Zeev Estrov, Gautam Borthakur, Naveen Pemmaraju, Marina Konopleva, Carlos Bueso-Ramos, Sherry Pierce, Hagop Kantarjian & Guillermo Garcia-Manero. (2017) Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents. American Journal of Hematology 92:7, pages 599-606.
Crossref
Antonio Almeida, Thomas Prebet, Raphael Itzykson, Fernando Ramos, Haifa Al-Ali, Jamile Shammo, Ricardo Pinto, Luca Maurillo, Jaime Wetzel, Pellegrino Musto, Arjan Van De Loosdrecht, Maria Costa, Susana Esteves, Sonja Burgstaller, Reinhard Stauder, Eva Autzinger, Alois Lang, Peter Krippl, Dietmar Geissler, Jose Falantes, Carmen Pedro, Joan Bargay, Guillermo Deben, Ana Garrido, Santiago Bonanad, Maria Diez-Campelo, Sylvain Thepot, Lionel Ades, Wolfgang Sperr, Peter Valent, Pierre Fenaux, Mikkael Sekeres, Richard Greil & Lisa Pleyer. (2017) Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study. International Journal of Molecular Sciences 18:4, pages 837.
Crossref
Ana Alfonso, Guillermo Montalban-Bravo & Guillermo Garcia-Manero. (2017) Current management of patients with chronic myelomonocytic leukemia. Current Opinion in Oncology 29:1, pages 79-87.
Crossref
Sonja Burgstaller. (2016) Treatment of chronic myelomonocytic leukemia. memo - Magazine of European Medical Oncology 9:4, pages 168-171.
Crossref
Mrinal M. Patnaik & Ayalew Tefferi. (2016) Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management. American Journal of Hematology 91:6, pages 631-642.
Crossref
Jean-Baptiste Fraison, Ars?ne Mekinian, Eric Grignano, Jean-Emmanuel Kahn, Jean-Benoit Arlet, Olivier Decaux, Guillaume Denis, Anne-Laure Buchdahl, Mohamed Omouri, Gwenola Maigne, Achille Aouba, Nathalie Leon, Sabine Berthier, Eric Liozon, Sophie Park, Claude Gardin, Olivier Lortholary, Julien Rossignol, Pierre Fenaux, Olivier Fain & Thorsten Braun. (2016) Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leukemia Research 43, pages 13-17.
Crossref
Mrinal M. Patnaik & Ayalew Tefferi. (2016) Chronic Myelomonocytic Leukemia: Focus on Clinical Practice. Mayo Clinic Proceedings 91:2, pages 259-272.
Crossref
Piyanuch Kongtim, Uday Popat, Antonio Jimenez, Sameh Gaballa, Riad El Fakih, Gabriela Rondon, Julianne Chen, Carlos Bueso-Ramos, Gautam Borthakur, Naveen Pemmaraju, Guillermo Garcia-Manero, Hagop Kantarjian, Amin Alousi, Chitra Hosing, Paolo Anderlini, Issa F. Khouri, Partow Kebriaei, Borje S. Andersson, Betul Oran, Katayoun Rezvani, David Marin, Elizabeth J. Shpall, Richard E. Champlin & Stefan O. Ciurea. (2016) Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia. Biology of Blood and Marrow Transplantation 22:1, pages 47-53.
Crossref
Kristen B. McCullough & Mrinal M. Patnaik. (2015) Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update. Current Hematologic Malignancy Reports 10:3, pages 292-302.
Crossref
David A. Sallman & Eric Padron. (2015) Transformation of the Clinical Management of CMML Patients Through In-Depth Molecular Characterization. Clinical Lymphoma Myeloma and Leukemia 15, pages S50-S55.
Crossref
M M Patnaik, E A Wassie, E Padron, F Onida, R Itzykson, T L Lasho, O Kosmider, C M Finke, C A Hanson, R P Ketterling, R Komrokji, A Tefferi & E Solary. (2015) Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome. Blood Cancer Journal 5:1, pages e270-e270.
Crossref
Mrinal M. Patnaik, Sameer A. Parikh, Curtis A. Hanson & Ayalew Tefferi. (2014) Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review. British Journal of Haematology 165:3, pages 273-286.
Crossref
Lisa Pleyer, Ulrich Germing, Wolfgang R. Sperr, Werner Linkesch, Sonja Burgstaller, Reinhard Stauder, Michael Girschikofsky, Martin Schreder, Michael Pfeilstocker, Alois Lang, Thamer Sliwa, Dietmar Geissler, Konstantin Schlick, Gudrun Placher-Sorko, Georg Theiler, Josef Thaler, Martina Mitrovic, Daniel Neureiter, Peter Valent & Richard Greil. (2014) Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival. Leukemia Research 38:4, pages 475-483.
Crossref
Pasquale NiscolaAndrea TendasLaura ScaramucciMarco GiovanniniDaniela PiccioniPaolo de Fabritiis. (2014) Acute myeloid leukemia arising from chronic myelomonocytic leukemia during hypomethylating therapy. Blood Research 49:1, pages 65.
Crossref
Sameer A. Parikh & Ayalew Tefferi. (2013) Chronic myelomonocytic leukemia: 2013 update on diagnosis, risk stratification, and management. American Journal of Hematology 88:11, pages 967-974.
Crossref
Antonio Almeida. (2013) Modifying disease in CMML: Who responds to Azacitidine?. Leukemia Research 37:6, pages 603-604.
Crossref
Massimo Breccia, Maria Teresa Voso & Giuliana Alimena. (2013) Chronic myelomonocytic leukemia treatment with azacitidine: What have we learned so far?. Leukemia Research 37:2, pages 204-205.
Crossref
Pasquale NiscolaAndrea TendasLaura ScaramucciMarco GiovanniniStefano FratoniPaolo de Fabritiis. (2013) Evolution of chronic myelomonocytic leukemia from refractory anemia: the unusual course of a myelodysplastic syndrome. Blood Research 48:2, pages 152.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.